Searchable abstracts of presentations at key conferences in endocrinology

ea0077p240 | Reproductive Endocrinology | SFEBES2021

Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: a systematic review and meta-analysis

Abdalla Mohammed , Shah Najeeb , Deshmukh Harshal , Sahebkar Amirhossein , Ostlundh Linda , Al-Rifai Rami H. , Atkin Stephen L , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) is a heterogeneous condition affecting women of reproductive age. It is associated with dyslipidaemia and elevated plasma C-reactive protein (CRP), which increase the risks of cardiovascular disease (CVD).Objective: To review the existing evidence on the effects of different pharmacological interventions on lipid profiles of women with PCOS.Data sources: We searched PubMed, MEDLINE, Scopus,...

ea0051oc4.3 | Oral Communications 4 | BSPED2017

Novel FOXA2 mutation causes hyperinsulinism, hypopituitarism with craniofacial dysmorphism and endoderm-derived organ abnormalities

Giri Dinesh , Vignola Marial Lillina , Gualtieri Angelica , Scagliotti Valeria , McNamara Paul , Peak Matthew , Didi Mohammed , Gaston-Massuet Carles , Senniappan Senthil

Background: Congenital hypopituitarism (CH) is characterised by the deficiency of one or more pituitary hormones and can present alone or in association with complex disorders. Congenital hyperinsulinism (CHI) is a disorder of unregulated insulin secretion despite hypoglycaemia that can occur in isolation or as part of a syndrome. The underlying genetic etiology causing the complex phenotype of CH and CHI is unknown.Patient and Methods: A female baby bor...

ea0051p005 | Thyroid | BSPED2017

Follicular thyroid carcinoma due to a heterozygous gain of function mutation in thyrotropin receptor (TSHR)

Blackburn James , Giri Dinesh , Seniappan Senthil , Didi Mohammed , Ciolka Barbara , Jones Matthew , Kokai George , Waghorn Alison , Gossan Nicole

Introduction: Activating mutations in thyrotropin receptor (TSHR) have been previously described in the context of non-autoimmune hyperthyroidism (familial or sporadic) and thyroid adenomas. We describe, for the first time, a mutation in TSHR contributing to follicular thyroid carcinoma (FTC) in an adolescent girl.Case: A 12-year-old girl presented with a right-sided neck swelling, increasing in size over the previous four weeks. Clinic...

ea0081p326 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Personalized glycemic response based Diabefly-Pro® digital therapeutics improves dietary patterns, glycemic control and reduces postprandial hyperglycemia in real-world settings

Joshi Shilpa , Verma Ritika , Khader Mohammed , Nikte Sneha , Ade Suresh , Bandukwala Saifuddin , Joshi Mitali , Methil Vinod , Tiwaskar Mangesh , Singal Arbinder

Background: CGM based monitoring can help in development of personalized digital therapeutics programs based on the understanding of the effect of diet, physical activity and medications on everyday blood glucose excursions. The variation in intra-individual glycemic response to the same food has been reported in many studies. Thus, understanding of personalized glycemic response (PGR) of each individual becomes important for effective diabetes management.<p class="abstext...

ea0081p480 | Thyroid | ECE2022

Radioactive iodine treatment in thyrotoxicosis- audit, Southampton general hospital

Salloum Mohammed , Al-Mrayat Ma'en , Sundram Francis , Bujonova Jana , Saad Ziauddin , Pilobello Nemia , Bray Diane , Knysak Alicja , Newland-Jones Philip

Hyperthyroidism is common and in iodine-sufficient parts of the world the prevalence of overt hyperthyroidism is estimated to be 0.2% to 1.3%. The treatment options include antithyroid medication (ATD), thyroid surgery, or Radioactive iodine (RAI). The latter is increasingly used as a first line definitive treatment for hyperthyroidism. We reviewed the outcomes of patients who received RAI at our tertiary nuclear medicine department over a 4-year period (May 2015 to Dec 2019) ...

ea0090ep671 | Pituitary and Neuroendocrinology | ECE2023

Medical complications of craniopharyngioma management in a uk tertiary pituitary centre

Tzanninis Stamatios , Jamsheed Mohammed , Zolnourian Ardalan , Knysak Alicja , Hempenstall Jonathan , Mathad Nijaguna , Bujanova Jana , Al-Mrayat Ma'en

Background: Craniopharyngioma (CP) is a rare sellar or suprasellar epithelial tumour with a prevalence of approximately 2 per million and it occurs either in childhood between the ages of 5 and 14 years or in adulthood between the ages of 50 and 74 years. Histologically, CPs are divided into adamantinomatous, more prevalent in children, and papillary, more prevalent in adults. They are usually benign, but rare cases of malignant CPs have been reported. Clinical presentation is...

ea0090ep986 | Thyroid | ECE2023

Thyroid hormone replacement during Ramadan fasting is a real challenge to hypothyroid patients. A systematic review and meta-analysis

Mohammed Rabea Eslam , Mohamed Belal Mohamed , Reda Youssef Asmaa , Awaad Elalaky Nessreen , Baker Hany , Adel Muhammed Quaisy Muhammed

Background: Ramadan is the religious month in which Muslims fast from pre-dawn (suhoor) until sunset (iftar), abstaining from all kinds of food, and liquid. The major change in meal times may be challenging for hypothyroid patients on levothyroxine because levothyroxine has a narrow therapeutic index and should be taken on an empty stomach.Objective: We aim to compare pre- and post-Ramadan Thyroid function tests of hypothyroid patients taking levothyroxi...

ea0041oc10.2 | Reproduction &amp; Endocrine Disruption | ECE2016

Human luteinizing hormone (hLH) and chorionic gonadotropin (hCG) display biased agonism at the LH/CG receptor

Riccetti Laura , Akli Ayoub Mohammed , Klett Daniele , Yvinec Romain , Gallay Nathalie , Combarnous Yves , Casarini Livio , Simoni Manuela , Reiter Eric

Human luteinizing hormone (LH) and human choriogonadotropin (hCG) were considered biologically equivalent for decades due to structural similarities and binding to the same receptor (LHCGR). However, LHCGR triggers differential, LH- and hCG-specific, cAMP production, steroidogenesis, ERK and AKT activation and gene expression in granulosa cells. Besides the Gs/cAMP/PKA pathway, hCG and LH bioactivity on β-arrestin- and Gq/PLC-dependent pathways are yet to be determined. W...

ea0059oc2.4 | The best of the best | SFEBES2018

Biochemical analysis of radioiodine uptake enhancement in endocrine cancer

Alshahrani Mohammed , Fletcher Alice , Thornton Caitlin , Brookes Kate , Nieto Hannah , Thompson Rebecca , Read Martin , Boelaert Kristien , McCabe Christopher , Smith Vicki

The most common form of endocrine cancer is differentiated thyroid cancer (DTC). Outcomes of DTC largely depend on radioiodine treatment, which is mediated the sodium-iodide symporter (NIS). However, many tumours exhibit NIS dysregulation, resulting in a poorer prognosis. Since breast cancer can also overexpress NIS, albeit of limited function, radioiodine treatment may be a promising treatment option. Our previous data show that overexpression of the pituitary tumor-transform...

ea0033p59 | (1) | BSPED2013

Screening log data can be used to inform protocol modifications, increasing patient recrutiment to a challanging clinical trial

Blair Jo , Awoyale Lola , Thornborough Keith , Peak Matthew , Didi Mohammed , Bedson Emma , Hughes Dyfrig , Ridyard Colin , Tat Tri , Gregory John

Background: Delivery of clinical trials to time and target is critical for studies to be financially viable and relevant. Feasibility studies are informative. However, protocol acceptability and recruitment rates can only be accurately ascertained once a study is open.The SCIPI study (SubCutaneous Insulin: Pumps or Injections?), randomises patients to treatment with multiple daily injections (MDI) or pumps at diagnosis of type I diabetes (TID). A consent...